As a Corporate Advisor, Jeremy brings to Intelligencia nearly three decades of experience at the intersection of healthcare, technology, data, and strategy. Through his work with high-growth healthcare companies and institutional investors, he has developed a unique perspective on how data-driven innovation is transforming life sciences, market access, and healthcare decision-making.
Jeremy is the Founder and Managing Partner of Brody Capital & Advisors (BC&A), a strategic advisory firm supporting entrepreneur-led businesses and investors across pharma technology and services, digital health, and data and analytics. Prior to founding BC&A, he served as Chief Strategy Officer at Aetion, a leading real-world evidence platform, and at Cerner Enviza, a global research and consulting organization. Earlier, at Kantar Health, he led corporate strategy and played a key role in the company’s successful acquisition by Cerner, now part of Oracle.
His career has consistently been at the forefront of healthcare innovation. Jeremy co-founded Jstreetdata.com, the first U.S. online physician market research panel, which was acquired by Interpublic Group in 2002. He began his professional journey at Covance Health Economics and Outcomes Services, helping pioneer approaches to market access and real-world evidence that have since become foundational to the life sciences industry.
Jeremy holds a Master of Science in Health Policy and Management from the Harvard School of Public Health and a Bachelor of Science from New York University. Outside of his professional work, he enjoys spending time with his wife, six sons, and two granddaughters, and produces live music events at a neighborhood café.
